Skip to content
Disclosery

ORBIMED ADVISORS LLC: SPRY position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on SPRY, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 8,288,510 SPRY shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 8,288,510 shares
    Change vs previous 13F 0 shares

    1.26% of the 13F portfolio, value $66,390,965.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 8,288,510 shares
    Change vs previous 13F 0 shares

    1.45% of the 13F portfolio, value $66,556,735.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 8,288,510 shares
    Change vs previous 13F 0 shares

    1.98% of the 13F portfolio, value $96,561,142.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 8,288,510 shares
    Change vs previous 13F 0 shares

    2% of the 13F portfolio, value $83,299,526.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 8,288,510 shares
    Change vs previous 13F 0 shares

    3.64% of the 13F portfolio, value $144,634,500.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 8,288,510 shares
    Change vs previous 13F 0 shares

    2.5% of the 13F portfolio, value $104,269,456.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 8,288,510 shares
    Change vs previous 13F 0 shares

    1.82% of the 13F portfolio, value $87,443,781.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 8,288,510 shares
    Change vs previous 13F not available

    2.2% of the 13F portfolio, value $120,183,395.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).